Cardiovascular Toxicities Associated with Tyrosine Kinase Inhibitors
Nicolas Sayegh, Juliet Yirerong, Neeraj Agarwal, Daniel Addison, Michael G. Fradley, Jörge E. Cortes, Neal L. Weintraub, Nazish Sayed, Girindra Raval, Avirup Guha
Topics & Concepts
MedicineTyrosine kinasePharmacologyInternal medicineReceptorChemotherapy-induced cardiotoxicity and mitigationChronic Myeloid Leukemia TreatmentsHER2/EGFR in Cancer Research